Claro Advisors LLC Astrazeneca PLC Transaction History
Claro Advisors LLC
- $706 Million
- Q3 2024
A detailed history of Claro Advisors LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Claro Advisors LLC holds 2,988 shares of AZN stock, worth $195,773. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,988
Previous 6,374
53.12%
Holding current value
$195,773
Previous $496,000
53.23%
% of portfolio
0.03%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding AZN
# of Institutions
1,361Shares Held
475MCall Options Held
5.39MPut Options Held
3.75M-
Price T Rowe Associates Inc Baltimore, MD62.9MShares$4.12 Billion0.56% of portfolio
-
Primecap Management CO Pasadena, CA42MShares$2.75 Billion2.45% of portfolio
-
Wellington Management Group LLP Boston, MA37.2MShares$2.44 Billion0.52% of portfolio
-
Capital International Investors Los Angeles, CA36.8MShares$2.41 Billion0.57% of portfolio
-
Franklin Resources Inc San Mateo, CA19.1MShares$1.25 Billion0.45% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $203B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...